EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr | ₹-164 Cr |
What is the latest Cash Flow from Investing Activities ratio of EMCURE PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-713 Cr |
Mar2023 | ₹-468 Cr |
Mar2022 | ₹-789 Cr |
Mar2021 | ₹-252 Cr |
Mar2020 | ₹-164 Cr |
How is Cash Flow from Investing Activities of EMCURE PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-713 Cr | Negative | |
Mar2023 | ₹-468 Cr | Negative | |
Mar2022 | ₹-789 Cr | Negative | |
Mar2021 | ₹-252 Cr | Negative | |
Mar2020 | ₹-164 Cr | - |
Compare Cash Flow from Investing Activities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,681.0 Cr | 9% | -0.6% | -4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 9% |
-0.6% |
-4.6% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses